Helsinn Birex Pharmaceuticals Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Helsinn Birex Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 680 Helsinn Birex Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Helsinn Birex Pharmaceuticals has purchased the following applications: IBM Cognos Analytics for Analytics and BI in 2010, Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2017, Infor CloudSuite EAM Asset Performance for Asset Performance Management in 2014 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Helsinn Birex Pharmaceuticals is running and its propensity to invest more and deepen its relationship with IBM , Tableau Software , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Helsinn Birex Pharmaceuticals revenues, which have grown to $288.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Helsinn Birex Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.